There is a good chance that Founderguard will be withdrawn from supply in the UK in the near future.

 

Whilst BEVA is broadly supportive of the drive to reduce the risk of antimicrobial resistance developing, we have asked the VMD to consider allowing existing patients to continue to be prescribed this medication.  

 

In the meantime, we would urge members to consider all alternatives to the use of Founderguard in horses and begin preparing owners for this products withdrawal from supply.